UBS Starts Vertex (VRTX) at Neutral; Near-Term Bias
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $505.75 -2.07%
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS initiates coverage on Vertex (NASDAQ: VRTX) with a Neutral. PT $56.
UBS analyst says, "Vertex is poised to lead a new era of hepatitis-C virus (HCV) antivirals with the recent FDA approval of Incivek, which we and the Street view as a potential blockbuster opportunity. Further, the HCV program is complemented by a novel and potentially transformative cystic fibrosis (CF) program, which we believe may address the vast majority of CF patients. We are initiating coverage of Vertex with a Neutral rating despite a near-term and long-term positive stance, given valuation, our view that upside to 2012-14 Incivek sales could be limited, and the longer timelines to key VX-809 data."
For more ratings news on Vertex click here and for the rating history of Vertex click here.
Shares of Vertex closed at $50.17 yesterday.
UBS analyst says, "Vertex is poised to lead a new era of hepatitis-C virus (HCV) antivirals with the recent FDA approval of Incivek, which we and the Street view as a potential blockbuster opportunity. Further, the HCV program is complemented by a novel and potentially transformative cystic fibrosis (CF) program, which we believe may address the vast majority of CF patients. We are initiating coverage of Vertex with a Neutral rating despite a near-term and long-term positive stance, given valuation, our view that upside to 2012-14 Incivek sales could be limited, and the longer timelines to key VX-809 data."
For more ratings news on Vertex click here and for the rating history of Vertex click here.
Shares of Vertex closed at $50.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital on Vertex (VRTX): 'SION Overhang Cleared; We Would Remain Buyers'
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
